Akoya Shares Gain on Unsolicited Third-Party Acquisition Proposal

Dow Jones05-22

By Katherine Hamilton

Shares of Akoya Biosciences rose after the developer of medical imaging tools said it was considering a third party's bid instead of the previously announced buyout by Quanterix.

Akoya stock climbed 26%, to $1.34, midday Wednesday. It is still down 42% this year.

The Marlborough, Mass., company said it had received an unsolicited acquisition proposal on Tuesday offering to buy it in an all-cash deal. Under the terms of the proposed deal, each Akoya share would be exchanged for $1.40.

Earlier this year, Akoya agreed to merge with Quanterix, which offered to pay Akoya shareholders 38 cents for a share and 0.1461 shares of Quanterix common stock. Quanterix shares declined 4%, to $4.77, on Wednesday.

Akoya is reviewing and considering the new proposal. It said the deal could be considered a superior proposal, meaning it would be inconsistent with the company's fiduciary duties if Akoya didn't engage in discussions with the third party.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

May 21, 2025 14:45 ET (18:45 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2537955953?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-22 02:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537955953","market":"sh","top_or_hot":-1,"title":"Akoya Shares Gain on Unsolicited Third-Party Acquisition Proposal","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Akoya Biosciences rose after the developer of medical imaging tools said it was considering a third party's bid instead of the previously announced buyout by Quanterix. \n</p>\n<p>\n  Akoya stock climbed 26%, to $1.34, midday Wednesday. It is still down 42% this year. \n</p>\n<p>\n  The Marlborough, Mass., company said it had received an unsolicited acquisition proposal on Tuesday offering to buy it in an all-cash deal. Under the terms of the proposed deal, each Akoya share would be exchanged for $1.40. \n</p>\n<p>\n  Earlier this year, Akoya agreed to merge with Quanterix, which offered to pay Akoya shareholders 38 cents for a share and 0.1461 shares of Quanterix common stock. Quanterix shares declined 4%, to $4.77, on Wednesday. \n</p>\n<p>\n  Akoya is reviewing and considering the new proposal. It said the deal could be considered a superior proposal, meaning it would be inconsistent with the company's fiduciary duties if Akoya didn't engage in discussions with the third party. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 21, 2025 14:45 ET (18:45 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Akoya Shares Gain on Unsolicited Third-Party Acquisition Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAkoya Shares Gain on Unsolicited Third-Party Acquisition Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-05-22 02:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Akoya Biosciences rose after the developer of medical imaging tools said it was considering a third party's bid instead of the previously announced buyout by Quanterix. \n</p>\n<p>\n  Akoya stock climbed 26%, to $1.34, midday Wednesday. It is still down 42% this year. \n</p>\n<p>\n  The Marlborough, Mass., company said it had received an unsolicited acquisition proposal on Tuesday offering to buy it in an all-cash deal. Under the terms of the proposed deal, each Akoya share would be exchanged for $1.40. \n</p>\n<p>\n  Earlier this year, Akoya agreed to merge with Quanterix, which offered to pay Akoya shareholders 38 cents for a share and 0.1461 shares of Quanterix common stock. Quanterix shares declined 4%, to $4.77, on Wednesday. \n</p>\n<p>\n  Akoya is reviewing and considering the new proposal. It said the deal could be considered a superior proposal, meaning it would be inconsistent with the company's fiduciary duties if Akoya didn't engage in discussions with the third party. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 21, 2025 14:45 ET (18:45 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2537955953","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537955953","pubTimestamp":1747853100,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Akoya Biosciences rose after the developer of medical imaging tools said it was considering a third party's bid instead of the previously announced buyout by Quanterix.Akoya stock climbed 26%, to $1.34, midday Wednesday. It is still down 42% this year.The Marlborough, Mass., company said it had received an unsolicited acquisition proposal on Tuesday offering to buy it in an all-cash deal. Under the terms of the proposed deal, each Akoya share would be exchanged for $1.40.Earlier this year, Akoya agreed to merge with Quanterix, which offered to pay Akoya shareholders 38 cents for a share and 0.1461 shares of Quanterix common stock. Quanterix shares declined 4%, to $4.77, on Wednesday.Akoya is reviewing and considering the new proposal. It said the deal could be considered a superior proposal, meaning it would be inconsistent with the company's fiduciary duties if Akoya didn't engage in discussions with the third party.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","BK4121":"生命科学工具和服务","AKYA":"Akoya Biosciences, Inc.","QTRX":"Quanterix Corp"},"translate_title":"Akoya股价因主动提出的第三方收购提案而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AKYA":0.9,"QTRX":0.9},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  Shares of Akoya Biosciences rose after the developer of medical imaging tools said it was considering a third party's bid instead of the previously announced buyout by Quanterix. \n\n\n  Akoya stock climbed 26%, to $1.34, midday Wednesday. It is still down 42% this year. \n\n\n  The Marlborough, Mass., company said it had received an unsolicited acquisition proposal on Tuesday offering to buy it in an all-cash deal. Under the terms of the proposed deal, each Akoya share would be exchanged for $1.40. \n\n\n  Earlier this year, Akoya agreed to merge with Quanterix, which offered to pay Akoya shareholders 38 cents for a share and 0.1461 shares of Quanterix common stock. Quanterix shares declined 4%, to $4.77, on Wednesday. \n\n\n  Akoya is reviewing and considering the new proposal. It said the deal could be considered a superior proposal, meaning it would be inconsistent with the company's fiduciary duties if Akoya didn't engage in discussions with the third party. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 21, 2025 14:45 ET (18:45 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2537955953","isCrawlerRequest":true}